| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.86e-08 | 10 | 63 | 4 | GO:0019531 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.92e-08 | 11 | 63 | 4 | GO:0008271 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 6.30e-08 | 13 | 63 | 4 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 6.30e-08 | 13 | 63 | 4 | GO:0140829 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 1.59e-07 | 16 | 63 | 4 | GO:0015116 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 2.66e-06 | 31 | 63 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 3.03e-06 | 32 | 63 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 3.03e-06 | 32 | 63 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 9.80e-06 | 2 | 63 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.10e-05 | 61 | 63 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.92e-04 | 207 | 63 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.03e-04 | 208 | 63 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.10e-04 | 320 | 63 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.62e-04 | 326 | 63 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.55e-04 | 125 | 63 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.49e-04 | 138 | 63 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | NADP binding | 9.91e-04 | 62 | 63 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor activity | 1.29e-03 | 17 | 63 | 2 | GO:0005092 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.32e-03 | 151 | 63 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.09e-03 | 171 | 63 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.31e-03 | 293 | 63 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase kinase binding | 3.03e-03 | 26 | 63 | 2 | GO:0031435 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 3.51e-03 | 28 | 63 | 2 | GO:0008320 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 5.15e-03 | 34 | 63 | 2 | GO:0022884 | |
| GeneOntologyBiologicalProcess | oxalate transport | 3.84e-08 | 12 | 63 | 4 | GO:0019532 | |
| GeneOntologyBiologicalProcess | sulfate transmembrane transport | 1.40e-07 | 16 | 63 | 4 | GO:1902358 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 5.40e-06 | 38 | 63 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 4.65e-05 | 65 | 63 | 4 | GO:0072348 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 8.89e-05 | 5 | 63 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 1.33e-04 | 6 | 63 | 2 | GO:0071256 | |
| Domain | S04_transporter_CS | 2.91e-09 | 7 | 58 | 4 | IPR018045 | |
| Domain | SLC26A | 1.73e-08 | 10 | 58 | 4 | PS01130 | |
| Domain | STAS | 2.72e-08 | 11 | 58 | 4 | PS50801 | |
| Domain | STAS_dom | 2.72e-08 | 11 | 58 | 4 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.72e-08 | 11 | 58 | 4 | IPR011547 | |
| Domain | STAS | 2.72e-08 | 11 | 58 | 4 | PF01740 | |
| Domain | SLC26A/SulP_fam | 2.72e-08 | 11 | 58 | 4 | IPR001902 | |
| Domain | - | 2.72e-08 | 11 | 58 | 4 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.72e-08 | 11 | 58 | 4 | PF00916 | |
| Domain | Plug_translocon | 9.48e-06 | 2 | 58 | 2 | PF10559 | |
| Domain | SecY_su_dom | 9.48e-06 | 2 | 58 | 2 | IPR023201 | |
| Domain | SecY | 9.48e-06 | 2 | 58 | 2 | PF00344 | |
| Domain | SECY_1 | 9.48e-06 | 2 | 58 | 2 | PS00755 | |
| Domain | SECY_2 | 9.48e-06 | 2 | 58 | 2 | PS00756 | |
| Domain | - | 9.48e-06 | 2 | 58 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 9.48e-06 | 2 | 58 | 2 | IPR019561 | |
| Domain | RabGDI | 9.48e-06 | 2 | 58 | 2 | IPR000806 | |
| Domain | SecY_CS | 9.48e-06 | 2 | 58 | 2 | IPR030659 | |
| Domain | DUF3697 | 9.48e-06 | 2 | 58 | 2 | PF12478 | |
| Domain | SecY/SEC61-alpha | 9.48e-06 | 2 | 58 | 2 | IPR002208 | |
| Domain | DUF3697_Uba2 | 9.48e-06 | 2 | 58 | 2 | IPR022166 | |
| Domain | GDI | 5.66e-05 | 4 | 58 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 5.66e-05 | 4 | 58 | 2 | IPR018203 | |
| Domain | Glyco_trans_31 | 1.11e-03 | 16 | 58 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 1.11e-03 | 16 | 58 | 2 | PF01762 | |
| Domain | NACHT | 2.30e-03 | 23 | 58 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 2.30e-03 | 23 | 58 | 2 | IPR007111 | |
| Domain | UBA | 3.90e-03 | 30 | 58 | 2 | SM00165 | |
| Domain | UBA | 5.58e-03 | 36 | 58 | 2 | PF00627 | |
| Domain | Homeobox | 6.00e-03 | 234 | 58 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.18e-03 | 236 | 58 | 4 | PS00027 | |
| Domain | HOX | 6.28e-03 | 237 | 58 | 4 | SM00389 | |
| Domain | HOMEOBOX_2 | 6.46e-03 | 239 | 58 | 4 | PS50071 | |
| Domain | Homeobox_dom | 6.46e-03 | 239 | 58 | 4 | IPR001356 | |
| Domain | UBA | 8.25e-03 | 44 | 58 | 2 | IPR015940 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 3.07e-06 | 9 | 48 | 3 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 3.07e-06 | 9 | 48 | 3 | MM15084 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 2.25e-04 | 35 | 48 | 3 | M16801 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 11087667 | ||
| Pubmed | Physiological roles and regulation of mammalian sulfate transporters. | 1.22e-09 | 9 | 63 | 4 | 11581495 | |
| Pubmed | N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. | 2.04e-09 | 10 | 63 | 4 | 24647542 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18480044 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 31201468 | ||
| Pubmed | Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6. | 3.23e-06 | 2 | 63 | 2 | 16606687 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 23660504 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28526688 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30118583 | ||
| Pubmed | The extracellular loop of pendrin and prestin modulates their voltage-sensing property. | 3.23e-06 | 2 | 63 | 2 | 29777056 | |
| Pubmed | Involvement of Cl(-)/HCO3(-) exchanger SLC26A3 and SLC26A6 in preimplantation embryo cleavage. | 3.23e-06 | 2 | 63 | 2 | 27346053 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16901991 | ||
| Pubmed | Functional Studies of Deafness-Associated Pendrin and Prestin Variants. | 3.23e-06 | 2 | 63 | 2 | 38474007 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11459928 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18565999 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 7585614 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 35633597 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12524348 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 26394631 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 26240314 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17170027 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 7543319 | ||
| Pubmed | Deletion of Slc26a6 alters the stoichiometry of apical Cl-/HCO-3 exchange in mouse pancreatic duct. | 9.68e-06 | 3 | 63 | 2 | 22895259 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 7513052 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 21068358 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 20969732 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 28941661 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 20164375 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 21976599 | ||
| Pubmed | The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. | 1.93e-05 | 4 | 63 | 2 | 10212142 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18762249 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18930060 | ||
| Pubmed | Role of down-regulated in adenoma anion exchanger in HCO3- secretion across murine duodenum. | 1.93e-05 | 4 | 63 | 2 | 19121635 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA MYOF FCGBP UBAP2 UBAP2L LTA4H QKI SEC61A1 GDI1 GDI2 NNT | 3.13e-05 | 1367 | 63 | 11 | 32687490 |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18667433 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 24233434 | ||
| Pubmed | GDI-1 preferably interacts with Rab10 in insulin-stimulated GLUT4 translocation. | 3.22e-05 | 5 | 63 | 2 | 19570034 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 9565615 | ||
| Pubmed | Mutations in DEPDC5 cause familial focal epilepsy with variable foci. | 3.22e-05 | 5 | 63 | 2 | 23542697 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 24753105 | ||
| Pubmed | Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport. | 3.22e-05 | 5 | 63 | 2 | 11929610 | |
| Pubmed | Acute knockdown of Depdc5 leads to synaptic defects in mTOR-related epileptogenesis. | 3.22e-05 | 5 | 63 | 2 | 32113911 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 24018950 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 16705175 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 11809807 | ||
| Pubmed | Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. | 4.82e-05 | 6 | 63 | 2 | 11834742 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 25220605 | ||
| Pubmed | Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Estonian families with hearing loss. | 8.98e-05 | 8 | 63 | 2 | 19027966 | |
| Pubmed | Genetic analysis of presbycusis by arrayed primer extension. | 8.98e-05 | 8 | 63 | 2 | 18988928 | |
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 20668687 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.02e-04 | 807 | 63 | 8 | 30575818 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.03e-04 | 256 | 63 | 5 | 35777956 | |
| Pubmed | Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina. | 1.15e-04 | 9 | 63 | 2 | 17729288 | |
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 28974734 | ||
| Pubmed | Placental, renal, and ileal sulfate transporter gene expression in mouse gestation. | 1.15e-04 | 9 | 63 | 2 | 22674389 | |
| Pubmed | Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism. | 1.32e-04 | 54 | 63 | 3 | 25464930 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 1.32e-04 | 54 | 63 | 3 | 25631074 | |
| Pubmed | 1.41e-04 | 437 | 63 | 6 | 20562859 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 29398364 | ||
| Pubmed | Cellular mechanotransduction relies on tension-induced and chaperone-assisted autophagy. | 1.44e-04 | 10 | 63 | 2 | 23434281 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 15711057 | ||
| Pubmed | 1.54e-04 | 148 | 63 | 4 | 22898364 | ||
| Pubmed | 1.71e-04 | 152 | 63 | 4 | 16009940 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 25336651 | ||
| Pubmed | 1.77e-04 | 653 | 63 | 7 | 22586326 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 22586092 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 9631292 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 39226364 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.28e-04 | 908 | 63 | 8 | 19274049 | |
| Pubmed | 2.49e-04 | 13 | 63 | 2 | 20335479 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 8733135 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 30753104 | ||
| Pubmed | 3.34e-04 | 15 | 63 | 2 | 35252209 | ||
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 3.34e-04 | 15 | 63 | 2 | 11698403 | |
| Pubmed | 3.34e-04 | 15 | 63 | 2 | 34927678 | ||
| Pubmed | 3.34e-04 | 15 | 63 | 2 | 9264260 | ||
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 3.40e-04 | 182 | 63 | 4 | 30711629 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.04e-04 | 344 | 63 | 5 | 30333137 | |
| Pubmed | 4.20e-04 | 347 | 63 | 5 | 16033648 | ||
| Pubmed | Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. | 4.32e-04 | 17 | 63 | 2 | 12589020 | |
| Pubmed | Gag-like proteins: Novel mediators of prenatal alcohol exposure in neural development. | 4.32e-04 | 17 | 63 | 2 | 35187673 | |
| Pubmed | 4.32e-04 | 17 | 63 | 2 | 7851895 | ||
| Pubmed | 4.85e-04 | 18 | 63 | 2 | 28728023 | ||
| Pubmed | Engrailed transcription factors direct excitatory cerebellar neuron diversity and survival. | 4.85e-04 | 18 | 63 | 2 | 38912572 | |
| Pubmed | Impact of ancestry and common genetic variants on QT interval in African Americans. | 5.41e-04 | 19 | 63 | 2 | 23166209 | |
| Pubmed | 5.41e-04 | 19 | 63 | 2 | 19805316 | ||
| Pubmed | Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS. | 5.41e-04 | 19 | 63 | 2 | 19036974 | |
| Pubmed | Combined Atoh1 and Neurod1 Deletion Reveals Autonomous Growth of Auditory Nerve Fibers. | 5.41e-04 | 19 | 63 | 2 | 32880858 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 6.63e-04 | 21 | 63 | 2 | 22216013 | |
| Pubmed | 6.63e-04 | 21 | 63 | 2 | 27856617 | ||
| Pubmed | The Epigenetic State of PRDM16-Regulated Enhancers in Radial Glia Controls Cortical Neuron Position. | 7.29e-04 | 22 | 63 | 2 | 29779941 | |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 7.40e-04 | 97 | 63 | 3 | 37151849 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 7.98e-04 | 400 | 63 | 5 | 35013556 | |
| Pubmed | 8.69e-04 | 24 | 63 | 2 | 23552073 | ||
| Pubmed | 8.69e-04 | 24 | 63 | 2 | 18635606 | ||
| Pubmed | 8.80e-04 | 103 | 63 | 3 | 10819331 | ||
| Pubmed | 9.05e-04 | 104 | 63 | 3 | 10470851 | ||
| Pubmed | 1.02e-03 | 26 | 63 | 2 | 24742657 | ||
| Pubmed | 1.02e-03 | 26 | 63 | 2 | 17875933 | ||
| Pubmed | 1.10e-03 | 27 | 63 | 2 | 31257105 | ||
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 2.34e-04 | 11 | 38 | 2 | 1315 | |
| GeneFamily | Beta 3-glycosyltransferases | 1.15e-03 | 24 | 38 | 2 | 426 | |
| GeneFamily | Solute carriers | 1.35e-03 | 395 | 38 | 5 | 752 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.05e-07 | 179 | 63 | 6 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-07 | 188 | 63 | 6 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.65e-06 | 173 | 63 | 5 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-06 | 174 | 63 | 5 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-06 | 175 | 63 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-06 | 179 | 63 | 5 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-06 | 179 | 63 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-06 | 184 | 63 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.28e-06 | 184 | 63 | 5 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 6.45e-06 | 185 | 63 | 5 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 63 | 5 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 185 | 63 | 5 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.62e-06 | 186 | 63 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-06 | 188 | 63 | 5 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-06 | 189 | 63 | 5 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 190 | 63 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.92e-06 | 193 | 63 | 5 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 8.54e-06 | 196 | 63 | 5 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.54e-06 | 196 | 63 | 5 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-06 | 196 | 63 | 5 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.54e-06 | 196 | 63 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.75e-06 | 197 | 63 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-06 | 197 | 63 | 5 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.75e-06 | 197 | 63 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-06 | 197 | 63 | 5 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.75e-06 | 197 | 63 | 5 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.75e-06 | 197 | 63 | 5 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.75e-06 | 197 | 63 | 5 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.97e-06 | 198 | 63 | 5 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 8.97e-06 | 198 | 63 | 5 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-06 | 199 | 63 | 5 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.19e-06 | 199 | 63 | 5 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.19e-06 | 199 | 63 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.19e-06 | 199 | 63 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 199 | 63 | 5 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.41e-06 | 200 | 63 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-3|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.30e-05 | 117 | 63 | 4 | 9a780218d67fa2c0bcdedd22984c4f52bce4b80e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 128 | 63 | 4 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-05 | 145 | 63 | 4 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.55e-05 | 153 | 63 | 4 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 156 | 63 | 4 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.06e-05 | 156 | 63 | 4 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-05 | 157 | 63 | 4 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.98e-05 | 161 | 63 | 4 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 162 | 63 | 4 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-05 | 166 | 63 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.98e-05 | 166 | 63 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.98e-05 | 166 | 63 | 4 | fcd0bd70b553789092249806ace324b77bd10481 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.98e-05 | 166 | 63 | 4 | b60954e5625743657d0fd9264b738b46e72fd8a6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.20e-05 | 167 | 63 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.20e-05 | 167 | 63 | 4 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 169 | 63 | 4 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.85e-05 | 170 | 63 | 4 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 9.85e-05 | 170 | 63 | 4 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.85e-05 | 170 | 63 | 4 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 172 | 63 | 4 | 63a91974b12c3f7f0c6bf66c30088d7fc07f5cea | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 172 | 63 | 4 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 173 | 63 | 4 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 174 | 63 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 178 | 63 | 4 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 178 | 63 | 4 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-04 | 179 | 63 | 4 | 2832a9ea1c84b809f4bb5fb39d7ad50af4b33fa9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 179 | 63 | 4 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 181 | 63 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 182 | 63 | 4 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 182 | 63 | 4 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.28e-04 | 182 | 63 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 183 | 63 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 183 | 63 | 4 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 183 | 63 | 4 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 183 | 63 | 4 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 183 | 63 | 4 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 183 | 63 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 184 | 63 | 4 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 184 | 63 | 4 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 185 | 63 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 185 | 63 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 185 | 63 | 4 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 185 | 63 | 4 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 185 | 63 | 4 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 185 | 63 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 185 | 63 | 4 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 185 | 63 | 4 | d1cfca6e85fa767253de7e8a14621989b816635f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 186 | 63 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 187 | 63 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 187 | 63 | 4 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 188 | 63 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 188 | 63 | 4 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.45e-04 | 188 | 63 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-04 | 188 | 63 | 4 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.48e-04 | 189 | 63 | 4 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 190 | 63 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 190 | 63 | 4 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 195 | 63 | 4 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| Disease | intraocular pressure measurement | 6.85e-05 | 509 | 59 | 7 | EFO_0004695 | |
| Disease | myopathy (implicated_via_orthology) | 1.23e-04 | 48 | 59 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | caudate volume change measurement | 3.52e-04 | 14 | 59 | 2 | EFO_0021491 | |
| Disease | sphingomyelin 14:0 measurement | 5.24e-04 | 17 | 59 | 2 | EFO_0010390 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTAAPIGLGYYGRYP | 1391 | Q9NR48 | |
| IGLGYYGRYPPTLYP | 1396 | Q9NR48 | |
| FPYVPFPGAFGVYEY | 136 | Q7RTU5 | |
| GPPGFRGPTEYYDTY | 336 | Q01955 | |
| PAGDLPYGYVYIPAL | 31 | O00155 | |
| AYGLPYGPRYVPEEP | 351 | C9J069 | |
| PYGLYYPSGPLDAGK | 661 | Q9UPQ7 | |
| PPGPEAGLIYTPYEY | 276 | Q96PU8 | |
| YGPEFYAVTGFPYPT | 201 | A6NFN3 | |
| PPFFHYRPGDYLYLN | 466 | Q96PH1 | |
| YYGPLLLMYVGPASP | 251 | A6NDH6 | |
| QYDLLVLPPSFPYGG | 256 | P09960 | |
| EGPFALPSYLYGDPL | 1421 | O75140 | |
| YYPVGPIYPPGSTVL | 91 | Q15038 | |
| KSPYLYPLYGLGELP | 221 | P50395 | |
| AKGYYRPYGVPVDAP | 406 | Q16787 | |
| VVFYVGGYPPDFKLP | 2536 | Q16787 | |
| TPFYPRSPYGAAKLY | 171 | O60547 | |
| FGGPLYPFPRTVNDY | 96 | Q03014 | |
| VFVPYGYLYPRSHPG | 326 | P22083 | |
| AYLSVGFYPVPGPRV | 101 | A8MTQ0 | |
| PPLYYPVDGYRVYQP | 491 | Q86TG7 | |
| LPGPFSYTVVLYGPA | 201 | Q9NX02 | |
| YYLLSALPQPKAPGY | 261 | Q32M88 | |
| PLLGRPLYYTSPFYG | 376 | Q9BZI1 | |
| YYGPLLFIYVGPASP | 251 | A6NKK0 | |
| VNYPLSPGLFSYLGP | 211 | P0CG20 | |
| DDRYYPLGQTFYPGP | 3596 | Q9Y6R7 | |
| APGSYLISIKYGGPY | 2491 | P21333 | |
| YPGTKYELGPALYLG | 151 | P56746 | |
| KSPYLYPLYGLGELP | 221 | P31150 | |
| AYGPTYMIYPGFLPT | 1671 | D6RIA3 | |
| PPIGFFTDYEIGPVY | 376 | Q9Y238 | |
| TAYVPVYPVGTPYAG | 176 | Q99946 | |
| GPDLPRIYPSFTYYH | 331 | Q16557 | |
| PPEYNYLYLLPAGTF | 591 | Q13423 | |
| PALPFYYYHIPALTG | 136 | Q9BXD5 | |
| VVPYGLLIFFPSYPV | 551 | Q9NZ71 | |
| YFRYKGVPFPVGLYS | 31 | O00204 | |
| YPVGGLCYYLSPPES | 336 | Q9H9S3 | |
| YLSEGFGYGMPPLYP | 736 | Q14934 | |
| GLPPVFGLYSSFYPV | 116 | Q9BXS9 | |
| AVPPIFGLYSSFYPV | 106 | P58743 | |
| FPLGQAGYPVYKYVP | 536 | O43272 | |
| TPYGYSTAAPAYGLP | 636 | Q96SI9 | |
| GYPNLHFPLRPYYVG | 101 | Q99935 | |
| PVPAYGAYLPNFYPV | 826 | Q01974 | |
| HEGPQYFYRGIYPPL | 71 | Q5H9E4 | |
| PPVYGLYASFFPAII | 101 | P40879 | |
| GPDLPRIYPSFTYYH | 331 | Q13046 | |
| IPEVVYSGLYPPYAG | 291 | Q9NY97 | |
| YYIPEAVYGLPAYPA | 271 | Q6UX72 | |
| FGYRPPSYSTAYLPG | 161 | O60248 | |
| VGPGGLLPAYPIYGY | 811 | Q5T6F2 | |
| APGLLHAYPPQVYGY | 806 | Q14157 | |
| GILGSRYGYIPPSYN | 971 | Q99973 | |
| VPVGYGLYSAFFPIL | 111 | O43511 | |
| YPVGGLCYYLSPPES | 336 | P61619 | |
| LFGPAPDLYFRPLYV | 181 | Q9P253 | |
| TFTGPLRPYFYVGPD | 441 | A6NK02 | |
| LPPGYYLYSQGLLTL | 86 | Q96B77 | |
| YGAYAFLPFDVPRLP | 216 | Q9BSE2 | |
| TFYPEPYPLVYGPQL | 916 | Q9P1Z0 | |
| QFLPYFVPGFSPYYA | 3306 | Q15911 | |
| LYGSPREYTGFPDPY | 506 | Q9NZM1 |